Study Reveals Inadequate Antifungal Dosing for ECMO Patients

Recent research indicates that antifungal medication dosages administered to patients undergoing Extracorporeal Membrane Oxygenation (ECMO) are often subtherapeutic. This finding suggests that current treatment protocols may be insufficient for a majority of ECMO patients, posing a significant challenge in critical care settings. The discovery highlights a need for re-evaluation of dosing strategies to improve patient outcomes.